Structured Treatment Interruption in Patients Infected with HIV

This publication has 25 references indexed in Scilit:

• Virologic and Immunologic Consequences of Discontinuing Combination Antiretroviral-Drug Therapy in HIV-Infected Patients with Detectable Viremia
  New England Journal of Medicine, 2001
• Mutation Takes No Vacation: Can Structured Treatment Interruptions Increase the Risk of Drug-Resistant HIV-1?
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
• Mutation Takes No Vacation: Can Structured Treatment Interruptions Increase the Risk of Drug-Resistant HIV-1?
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
• Risks and benefits of structured antiretroviral drug therapy interruptions in HIV-1 infection
  AIDS, 2000
• Enhancement of Human Immunodeficiency Virus Type 1–Specific CD4 and CD8 T Cell Responses in Chronically Infected Persons after Temporary Treatment Interruption
  The Journal of Infectious Diseases, 2000
• HIV-1–specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy
  Journal of Clinical Investigation, 1999
• Control of HIV despite the Discontinuation of Antiretroviral Therapy
  New England Journal of Medicine, 1999
• HIV-1 rebound during interruption of highly active antiretroviral therapy has no deleterious effect on reinitiated treatment
  AIDS, 1999
• Changing patterns of mortality across Europe in patients infected with HIV-1
  The Lancet, 1998
• Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1998